6.42
-0.53(-7.63%)
Currency In USD
| Previous Close | 6.95 |
| Open | 6.94 |
| Day High | 7 |
| Day Low | 6.33 |
| 52-Week High | 34.4 |
| 52-Week Low | 3.44 |
| Volume | 83,735 |
| Average Volume | 150,891 |
| Market Cap | 47.07M |
| PE | -1.23 |
| EPS | -5.2 |
| Moving Average 50 Days | 8.01 |
| Moving Average 200 Days | 11.36 |
| Change | -0.53 |
If you invested $1000 in Biodesix, Inc. (BDSX) since IPO date, it would be worth $25.06 as of October 19, 2025 at a share price of $6.42. Whereas If you bought $1000 worth of Biodesix, Inc. (BDSX) shares 3 years ago, it would be worth $305.71 as of October 19, 2025 at a share price of $6.42.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Biodesix Announces Presentations and Events at the CHEST 2025 Annual Meeting
GlobeNewswire Inc.
Oct 15, 2025 10:09 AM GMT
One year after launch of real-world CLARIFY study, preliminary data from the first 1,000 enrolled patients will be presentedLOUISVILLE, Colo., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostics solutions company,
Biodesix Unveils October Lung Health Events in Colorado with the Association of Pulmonary Advanced Practice Providers (APAPP), American Lung Association in Colorado, and GO2 for Lung Cancer Centers of Excellence Summit
GlobeNewswire Inc.
Oct 06, 2025 2:13 PM GMT
Biodesix partners with three leading Lung Health organizations to bring education and advocacy to healthcare professionals and patients LOUISVILLE, Colo., Oct. 06, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostics soluti
Biodesix Announces One-for-Twenty Reverse Stock Split
GlobeNewswire Inc.
Sep 11, 2025 12:00 PM GMT
LOUISVILLE, Colo., Sept. 11, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX) (“Biodesix” or the “Company”), a leader in personalized diagnostics, today announced a one-for-twenty reverse stock split (the “Reverse Stock Split”) of the Company